September 2013 FDA Recall Drug by Hospira, Inc.
D-023-2014 - Lack of Assurance of Sterility

This Class II drug recall was voluntarily initiated by Hospira, Inc. on September 16, 2013 for the product Drug. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-023-2014

Reason for Recall
Lack of Assurance of Sterility: Confirmed customer report of leakage of vial contents due to the breaking of the vial neck.
Initiated
09-16-2013
Reported
12-11-2013
Quantity
29,700 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Morphine Sulfate Injection, USP, (25mg/mL), 250 mg, 10mL Fill, Single dosage Flip top Vial, (C-II), (NDC 0409-1135-02), Rx Only, Manfactured for Hospira, Inc., Lake Forest, IL 60045 USA.

Batch or Lot Expiration Information

Lot# 17368EV Exp 08/13